Retrospective Study on the Evolution of CIN 1 to 3 in Per and Postpartum in Nancy From 2014 to 2022

Central Hospital, Nancy, France

Status: Invitation-only

Conditions: Cervical Intraepithelial Neoplasia

Treatments: Biological: cervical biopsy

Study type: Observational

Funder types: Other

Identifiers

NCT05595252

2022PI157/EUDRACT

Details and patient eligibility

About

In France, the screening rate for cervical cancer remains too low. Screening is simple and non-invasive.

Pregnant patients are most of the time young and are part of the target population for screening, and for many women, it is the first encounter with a gynecologist.

The cervical smear is therefore an important step of the first consultation during pregnancy In the case of pathological results, colposcopies with biopsies are performed, frequently finding CIN 1 to 3. (cervical intraepithelial neoplasia) These CIN lesions evolve slowly and most of the time, treatment can be withheld until the end of the pregnancy.

Several studies suggest a higher regression rate in pregnant patients. Our study will evaluate the rate of regression, progression or persistence of these lesions in per and post partum patients in Nancy, between 2014 and 2022.

To obtain our results, we will compare the results of per and post partum biopsies in each patient.

In a second step, we will study the risk factors of aggravation or on the contrary the protective factors, allowing a faster regression of the lesions

Enrollment: 100 estimated patients

Sex: Female

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• women who have a CIN lesion during pregnancy
• in Nancy, France, MRUN Center
• between 2014 and 2022

Exclusion criteria

• lost of follow up women

Trial design

100 participants in 1 patient group

Patients with CIN lésions during pregnancy

Treatment:

Biological: cervical biopsy